Efficacy and safety of olokizumab in the treatment of rheumatoid arthritis in real clinical practice in Kazakhstan
Objective: Olokizumab (OKZ) is one of the innovative biologic treatments for rheumatoid arthritis (RA) targeting interleukin-6 (IL-6). The study purpose was to evaluate the 24-week efficacy and safety of OKZ in routine clinical practice among RA patients in Kazakhstan, filling a gap in existing rese...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2020-12-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1732 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|